As per the research report, the size of the Middle East and Africa Cardiac Surgery Devices Market is valued at USD 0.13 billion in 2022 and estimated to be growing at a CAGR of 2.6%, reaching USD 0.15 billion by 2027 during the forecast period 2022 to 2027.
Surgery for the heart and blood vessels Cardiac surgery and other cardiovascular treatments use devices and technology to correct structural problems of the heart's circulatory system, including damaged or blocked valves and arteries.
The MEA Cardiac surgery devices market is expected to be driven by the factors such as the increasing prevalence of cardiovascular disorders and the growing prevalence of surgical procedures across the region. Also, the rising demand for minimally invasive surgeries in the area is estimated to fuel the market growth.
The growing senior population across the region is considered a significant growth contributor to the market. In addition, older people are more prone to various chronic diseases such as stroke, cardiac arrest, cardiomyopathy, and arrhythmias that influence the demand for cardiac surgery devices.
In addition, the technological advancements in the healthcare sector and the growing adoption of innovative advanced cardiac surgery devices support the market growth.
The rapid evolution of electronic data collection during cardiac surgery is projected to push cardiac surgery device manufacturers to create one-of-a-kind solutions soon. As a result, several data management systems that enable seamless data integration from the heart-lung machine have been developed.
The increasing investment and funding by the government for the development of healthcare infrastructure and research and development activities are expected to boost the market growth.
Government initiatives to create awareness among the people about the prevalence of cardiac diseases and the availability of treatment procedures through medical tourism and other awareness programs positively influence market growth.
Other factors such as increasing healthcare expenditure and improving healthcare infrastructure in emerging countries like the UAE, South Africa, and Saudi Arabia contribute to the expansion of MEA regional markets.
Furthermore, the major companies and the market participants are implementing various market strategies to gain a competitive advantage over the marketplace.
However, the shortage of medical professionals and alternative medical devices is expected to restrain the market growth.
This research report on the MEA Cardiac Surgery Devices Market has been segmented and sub-segmented into the following categories.
By Product Type:
By Age Group:
Geographically, the market of the Middle East & Africa cardiac surgery devices is projected to grow at a moderate pace during the forecast period. The regional market growth is driven owing to the improving healthcare sector, the Presence of key market players, and the implementation of market strategies and favorable reimbursement policies. The major contributors in the region are South Arica, UAE, and Saudi Arabia.
The South African cardiac surgery devices market recorded the majority share of the MEA cardiac surgery devices market due to the increasing disposable income of individuals, technological advancement in the healthcare sector and growing awareness are propelling the market growth. The most recent technology is being used. Short circuits in the heart can be ablated with a heated catheter tip using the Sensei Robotic Catheter system. This restores the heart's rhythm and eliminates the need for other therapies such as pacemakers and medications.
The Saudi Arabia cardiac surgery devices market is projected to showcase a promising share in the market. The factors such as the growing population and associated lifestyle disorders, the increasing obese population, and Supportive government policies are fueling the market growth.
KEY MARKET PLAYERS
Promising companies dominating the MEA Cardiac Surgery Devices Market profiled in the report are Trinity Biotech, Abiomed, Inc., Cardinal Health, MedWaves Incorporated, CyberHeart Incorporated, C. R. Bard, Inc., and Transmedics, Inc., among others.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org